Pre-conference program: Leveraging the FDA HCEI guidance to expand payer engagement through a comprehensive HCEI strategy

Developing a comprehensive HCEI strategy for your product is essential to creating a strong value story and effectively engaging with payers to inform decision-making.

Xcenda is partnering with AMCP to conduct the second HCEI-focused corporate training workshop at the 2023 AMCP Annual Meeting & Exposition in San Antonio, TX on March 21st. Featuring insights and expertise from academia, biopharma companies, and payers, Leveraging the FDA HCEI Guidance to expand payer engagement through a comprehensive HCEI strategy will provide you with latest information and trends to help enhance your HCEI strategy. Get insights on:

• The impact of the FDA 2018 Guidance and the 21st Century Cures on HCEI strategy
• Importance of internal alignment on data sets to drive value from a payer perspective
• Common internal challenges in developing HCEI for payers and how to avoid them
• Building a timeline from PIE to HCEI and tactics to support your communication strategy
• Effective communications strategies to maximize your reach to payer
   

Register for the pre-conference training through the AMCP2023 registration page
_{Note: if you have already registered for AMCP 2023, please contact Lauren Chan at lchan@amcp.org to have the corporate training program added to your existing registration.}

Join Kimberly Westich, Director of Value & Access Strategy, as she moderates an AMCP Talks on value frameworks. This AMCP Talks session will explore real-world strategies for incorporating value assessment into coverage and reimbursement decision-making and learn more about the payer decision-making processes and how they can differ among organizations.